BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24696415)

  • 1. Increased expression of claudin-1 and claudin-7 in liver cirrhosis and hepatocellular carcinoma.
    Holczbauer Á; Gyöngyösi B; Lotz G; Törzsök P; Kaposi-Novák P; Szijártó A; Tátrai P; Kupcsulik P; Schaff Z; Kiss A
    Pathol Oncol Res; 2014 Jul; 20(3):493-502. PubMed ID: 24696415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricellulin expression and its prognostic significance in primary liver carcinomas.
    Somorácz A; Korompay A; Törzsök P; Patonai A; Erdélyi-Belle B; Lotz G; Schaff Z; Kiss A
    Pathol Oncol Res; 2014 Oct; 20(4):755-64. PubMed ID: 24652413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
    Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
    In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients.
    Farid RM; Abu-Zeid RM; El-Tawil A
    Int J Clin Exp Pathol; 2014; 7(5):2707-17. PubMed ID: 24966992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA
    Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma.
    Chava S; Lee C; Aydin Y; Chandra PK; Dash A; Chedid M; Thung SN; Moroz K; Wu T; Nayak NC; Dash S
    Oncotarget; 2017 Jun; 8(25):40019-40036. PubMed ID: 28402954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
    Pereira Tde A; Witek RP; Syn WK; Choi SS; Bradrick S; Karaca GF; Agboola KM; Jung Y; Omenetti A; Moylan CA; Yang L; Fernandez-Zapico ME; Jhaveri R; Shah VH; Pereira FE; Diehl AM
    Lab Invest; 2010 Dec; 90(12):1690-703. PubMed ID: 20697376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma.
    Szabó E; Korpos E; Batmunkh E; Lotz G; Holczbauer A; Kovalszky I; Deák F; Kiss I; Schaff Z; Kiss A
    Pathol Oncol Res; 2008 Mar; 14(1):15-22. PubMed ID: 18386166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
    Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
    Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.
    Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Straub BK; Schirmacher P; Kovalszky I; Lotz G; Kiss A; Schaff Z
    Virchows Arch; 2011 Jun; 458(6):679-88. PubMed ID: 21503766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
    J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.
    Iyer JK; Kalra M; Kaul A; Payton ME; Kaul R
    World J Gastroenterol; 2017 Oct; 23(37):6802-6816. PubMed ID: 29085224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
    El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
    MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma.
    Bai X; Wu L; Liang T; Liu Z; Li J; Li D; Xie H; Yin S; Yu J; Lin Q; Zheng S
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):83-91. PubMed ID: 17611778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
    Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
    Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.